There is a need for early identification of children with immunoglobulin A nephropathy (IgAN) at risk of progression of kidney disease. Data on 261 young patients [age 0.4 g/day/1.73 m(2) and an eGFR of 90 ml/min/1.73 m(2)) at presentation had a significantly high probability of proteinuria remission during follow-up and a higher remission rate following treatment with corticosteroid and/or immunosuppressive therapy.
This new statistical approach has identified clinical and histological risk factors associated with outcome in children and young adults with IgAN.